Clover Health Investments Research and Development Expenses 2020-2024 | CLOV
Clover Health Investments Annual Research and Development Expenses (Millions of US $) |
|
---|---|
2023 | $ |
2022 | $ |
2021 | $ |
2020 | $ |
2019 | $ |
Clover Health Investments Quarterly Research and Development Expenses (Millions of US $) |
|
---|---|
2024-06-30 | |
2024-03-31 | |
2023-12-31 | |
2023-09-30 | |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | |
2021-06-30 | |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.492B | $2.034B |
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
Tempus AI (TEM) | United States | $7.918B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
Axonics (AXNX) | United States | $3.513B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
10x Genomics (TXG) | United States | $2.660B | 0.00 |
Enovis (ENOV) | United States | $2.437B | 17.67 |
Azenta (AZTA) | United States | $2.413B | 137.03 |
Privia Health (PRVA) | United States | $2.280B | 158.92 |
IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
Omnicell (OMCL) | United States | $1.968B | 64.82 |
Schrodinger (SDGR) | United States | $1.436B | 0.00 |
Phreesia (PHR) | United States | $1.389B | 0.00 |
Standard BioTools (LAB) | United States | $0.753B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
Talkspace (TALK) | United States | $0.343B | 0.00 |
Pulmonx (LUNG) | United States | $0.329B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
TruBridge (TBRG) | United States | $0.183B | 13.44 |
P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
American Well (AMWL) | United States | $0.147B | 0.00 |
Augmedix (AUGX) | United States | $0.115B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
111 (YI) | China | $0.051B | 0.00 |
Zepp Health (ZEPP) | China | $0.049B | 0.00 |
CareCloud (CCLD) | United States | $0.045B | 0.00 |
Movano (MOVE) | United States | $0.036B | 0.00 |
Outset Medical (OM) | United States | $0.034B | 0.00 |
MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Syra Health (SYRA) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |